Active	Status	Sponsor type	Region	Phase	Filter
2 Active 1 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Khan, Naimat
NCT05332704: Safety, Tolerability, PK, PD and Preliminary Efficacy of ONO-4685	Suspended	1	74	Europe, RoW	ONO-4685, Placebo	Ono Pharmaceutical Co. Ltd	Plaque Psoriasis	10/24	12/25